- Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
- Browse: 385 Download: 895 Issue Date: 2024-10-21
- Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
- Browse: 435 Download: 1042 Issue Date: 2024-09-23
- Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
- Browse: 351 Download: 1023 Issue Date: 2024-09-23
- Immune remodulation in pediatric inherited metabolic liver diseases
- Browse: 306 Download: 846 Issue Date: 2024-09-23
- Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
- Browse: 340 Download: 942 Issue Date: 2024-09-23
- Kick-start for metabolomics in liver disease
- Browse: 440 Download: 879 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 356 Download: 978 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 446 Download: 1076 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 424 Download: 918 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 404 Download: 728 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 336 Download: 721 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 598 Download: 1131 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 473 Download: 1352 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 570 Download: 982 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 451 Download: 1016 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 488 Download: 1058 Issue Date: 2024-07-26
- Successful treatment of severe hepatic impairment in erythropoietic protoporphyria: A case report and review of literature
- Browse: 536 Download: 1075 Issue Date: 2024-06-27
- Liver histological changes in untreated chronic hepatitis B patients in indeterminate phase
- Browse: 478 Download: 1349 Issue Date: 2024-06-27
- Importance of the gut microbiota in the gut-liver axis in normal and liver disease
- Browse: 476 Download: 805 Issue Date: 2024-06-27
- Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both
- Browse: 386 Download: 767 Issue Date: 2024-06-27